Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes With PrognosisKaren Dybkær, Hans Erik Johnsen, Sara Correia Marques et al.|Journal of Clinical Oncology|2015Cited by 125
High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphomaSara Correia Marques, Karen Dybkær, Benyamin Ranjbar et al.|Experimental Hematology|2016Cited by 68
MicroRNAs in B-cells: from normal differentiation to treatment of malignanciesSara Correia Marques, Karen Dybkær, Maria Bach Laursen et al.|Oncotarget|2014Cited by 26
MicroRNAs as novel biomarkers in diffuse large B-cell lymphoma--a systematic review.Laura Krogh Jørgensen, Karen Dybkær, Mette Østergaard Thunbo et al.|PubMed|2015Cited by 14
Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-CellsBenyamin Ranjbar, Jacob Giehm Mikkelsen, Louise Bechmann Krogh et al.|PLoS ONE|2016Cited by 4